About
Overview
Management Team
Board of Directors
Clinical Advisors
Strategic Collaborations (MJFF)
Contact Us
Product Pipeline
APL-130277 Overview
APL-130277 Clinical Trials
APL-130277 Published Data
Parkinson's Disease
Overview
Treatment of Parkinson's Disease
OFF Episodes in Parkinson's Disease
Current Treatment of OFF Episodes
About Apomorphine
Parkinson's Resources
Investors
Company Info
Company Information
Profile
Presentations
Management Team
Contacts
FAQ
News / Events
News / Events
Press Releases
IR Calendar
Email Alerts
Financial Info
Financial Results
Stock Data
Stock Data
Quote: CYNA
Quote: CTH
Analyst Coverage
Analyst Coverage
SEC / OSC
SEC/EDGAR
Annual Reports
Quarterly Reports
OSC/SEDAR
Governance
Corporate Governance
Board of Directors
Board Committees
Governance Documents
PFIC Info
PFIC Statements
News
Press Releases
In The News
Careers
Investors
Company Info
Overview
Profile
Presentations
Management Team
Contacts
FAQ
News / Events
Overview
Press Releases
IR Calendar
Email Alerts
Financial Info
Financial Results
Stock Data
Overview
Quote: CYNA
Quote: CTH
Analyst Coverage
Overview
SEC / OSC
SEC/EDGAR
Annual Reports
Quarterly Reports
OSC/SEDAR
Governance
Overview
Board of Directors
Board Committees
Governance Documents
PFIC Info
PFIC Statements
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
SEC/EDGAR
Filter Filings:
View All
10-K
10-K/A
10-Q
144
144/A
8-A12B
8-K
CERTNAS
CT ORDER
D
D/A
EFFECT
F-10
F-10/A
F-X
FWP
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SUPPL
Date
Form
Description
Docs
XBRL
Pages
10/11/16
8-K
Current report filing
3
10/11/16
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
13
09/29/16
8-K
Current report filing
Related Documents
EX-99.1
6
09/27/16
CT ORDER
Confidential treatment order
1
09/19/16
8-K
Current report filing
3
09/16/16
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Related Documents
EX-99.A
8
09/16/16
8-K
Current report filing
Related Documents
EX-99.1
EX-99.2
EX-99.3
EX-99.4
190
09/15/16
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Related Documents
EX-99.2
EX-99.3
35
09/12/16
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
10
09/07/16
8-K
Current report filing
3
1
2
3
4
5
6
7
8
Next >>